Ardelyx (ARDX) Retained Earnings (2013 - 2026)
Ardelyx (ARDX) reported Retained Earnings of -$984.5 million for Q1 2026, down 5469788.89% on a YoY basis from N/an in Q1 2025, and down 3.97% quarter-over-quarter from -$946.9 million in Q4 2025.
Ardelyx (ARDX) Retained Earnings (2013 - 2026) Analysis & Trends
Ardelyx has reported Retained Earnings for 14 years, with the latest figure at -$984.5 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 5469788.89% year-over-year to -$984.5 million; the trailing twelve-month figure through Mar 2026 stood at -$984.5 million (down 5469788.89% YoY), and the FY2025 full-year result was -$946.9 million, down 6.96% from the prior year.
- Retained Earnings for Q1 2026 stood at -$984.5 million, down from -$946.9 million in the prior quarter.
- The five-year high for Retained Earnings was $224000.0 in Q4 2023, with the low at -$984.5 million in Q1 2026.
- Historically, Retained Earnings has averaged -$515.9 million across 5 years, with a median of -$806.9 million in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings jumped 514.81% — and 2026, when it sank 5469788.89%.
- Ardelyx's Retained Earnings stood at -$54000.0 in 2022, then jumped by 514.81% to $224000.0 in 2023, then slumped by 395341.07% to -$885.3 million in 2024, then slipped by 6.96% to -$946.9 million in 2025, then slipped by 3.97% to -$984.5 million in 2026.
- The last three Retained Earnings figures came in at -$984.5 million (Q1 2026), -$946.9 million (Q4 2025), and -$946.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -984.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -984.54 Mn |
| Dec 31, 2025 | -946.94 Mn |
| Sep 30, 2025 | -946.53 Mn |
| Jun 30, 2025 | -945.56 Mn |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | -885.34 Mn |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | -872.72 Mn |
| Dec 31, 2023 | 224,000.00 |
| Sep 30, 2023 | -817.40 Mn |
| Jun 30, 2023 | -824.03 Mn |
| Mar 31, 2023 | -806.90 Mn |
| Dec 31, 2022 | -54,000.00 |
| Sep 30, 2022 | -114,000.00 |
| Jun 30, 2022 | -109,000.00 |
| Mar 31, 2022 | -741.00 Mn |
| Dec 31, 2021 | -712.93 Mn |
| Sep 30, 2021 | -676.70 Mn |
| Jun 30, 2021 | 4,000.00 |